使用避孕植入物使用者的不良出血模式的治疗:随机临床试验
Alison Edelman1, Emily Boniface1, Marci Messerle-Forbes1
1Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
American journal of obstetrics and gynecology
|January 9, 2026
概括
特兰胺酸 (TXA) 没有减少埃托诺斯特勒 (ENG) 植入物使用者的频繁或长时间出血. 与安慰剂相比,这5天的治疗过程没有显著改善出血模式或满意度.
科学领域:
- 避孕和计划生育与计划生育.
- 药理学 药理学是指药理学的学科.
- 妇科 妇科医生 妇科
背景情况:
- 乙格斯特勒 (ENG) 植入物是有效的避孕药,但通常会导致令人烦的出血.
- 由于其复杂的原因,存在有限的临床策略来管理与ENG植入物相关的出血.
- 特兰克萨姆酸 (TXA) 是一种抗纤维解药,用于妇科出血,但尚未研究ENG植入物.
研究的目的:
- 评估特兰胺酸 (TXA) 是否可以降低ENG植入物使用者的频繁或长期出血.
- 评估TXA在管理与乙格斯特勒植入物相关的不规则出血模式中的有效性.
主要方法:
- 进行了一项随机,双盲,安慰剂控制的试验.
- 患有频繁/持续出血的NG植入物使用者接受TXA (1300毫克三次) 或安慰剂5天.
- 通过电子日记追踪每日出血模式;主要结果是30天内没有出血/斑点的日期.
主要成果:
- 在65名随机选择的参与者中,83%完成了30天的监测期.
- 在TXA和安慰剂组 (每组19天) 之间,没有出血/斑点的中位数日没有显著差异.
- 出血日,出血发作和参与者的满意度在各组之间没有显著差异.
结论:
- 一个为期5天的特兰胺酸 (TXA) 疗程并没有改善乙格斯特 (ENG) 植入物使用者的出血问题.
- 在减少与ENG避孕植入物相关的频繁或长期出血模式方面,TXA无效.
相关概念视频
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192


